Molecular Probes for Pancreatic Cancer Imaging
Pancreatic ductal adenocarcinoma (PDAC) has the poorest five-year survival rate of any cancer. Currently, there are no effective diagnostics or chemotherapeutics. Surgical resection is the only curative therapy. However, most patients experience recurrence due largely to challenges in assessing tumo...
Main Author: | |
---|---|
Format: | Others |
Published: |
PDXScholar
2016
|
Subjects: | |
Online Access: | http://pdxscholar.library.pdx.edu/open_access_etds/3108 http://pdxscholar.library.pdx.edu/cgi/viewcontent.cgi?article=4120&context=open_access_etds |